American Shared Hospital Services (NYSEAMERICAN:AMS) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in a report issued on Wednesday. The brokerage issued a hold rating on the stock.

American Shared Hospital Services Stock Performance

Shares of NYSEAMERICAN:AMS opened at $3.17 on Wednesday. The company has a current ratio of 1.98, a quick ratio of 1.98 and a debt-to-equity ratio of 0.49. American Shared Hospital Services has a 1-year low of $2.16 and a 1-year high of $3.69. The firm has a market cap of $20.07 million, a price-to-earnings ratio of 39.63 and a beta of 0.70.

American Shared Hospital Services (NYSEAMERICAN:AMS) last announced its quarterly earnings data on Tuesday, May 14th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). American Shared Hospital Services had a net margin of 2.50% and a return on equity of 4.29%. The firm had revenue of $5.22 million during the quarter, compared to the consensus estimate of $5.01 million. As a group, research analysts expect that American Shared Hospital Services will post 0.29 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in American Shared Hospital Services stock. Empowered Funds LLC acquired a new stake in American Shared Hospital Services (NYSEAMERICAN:AMS) in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 10,468 shares of the company’s stock, valued at approximately $31,000. Empowered Funds LLC owned about 0.17% of American Shared Hospital Services as of its most recent filing with the Securities & Exchange Commission. 23.16% of the stock is owned by institutional investors and hedge funds.

American Shared Hospital Services Company Profile

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.